Jerad Suresh

970 total citations
37 papers, 854 citations indexed

About

Jerad Suresh is a scholar working on Organic Chemistry, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Jerad Suresh has authored 37 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 8 papers in Pharmacology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Jerad Suresh's work include Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Jerad Suresh is often cited by papers focused on Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Jerad Suresh collaborates with scholars based in India, United States and Türkiye. Jerad Suresh's co-authors include Bijo Mathew, Githa Elizabeth Mathew, S. Anbazhagan, Gülberk Uçar, Monu Joy, Venkatesan Jayaprakash, İpek Baysal, Hoon Kim, Seung Cheol Baek and Vinod Devaraji and has published in prestigious journals such as International Journal of Biological Macromolecules, Journal of Molecular Liquids and Journal of Molecular Structure.

In The Last Decade

Jerad Suresh

35 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerad Suresh India 18 550 370 206 156 135 37 854
Elías Quezada Spain 16 592 1.1× 341 0.9× 265 1.3× 123 0.8× 83 0.6× 49 1.1k
Melissa D’Ascenzio Italy 24 805 1.5× 410 1.1× 505 2.5× 112 0.7× 91 0.7× 32 1.2k
Lesetja J. Legoabe South Africa 19 601 1.1× 291 0.8× 338 1.6× 117 0.8× 82 0.6× 79 1.1k
Olivia Befani Italy 23 744 1.4× 305 0.8× 562 2.7× 119 0.8× 136 1.0× 47 1.5k
Saleta Vázquez-Rodríguez Spain 19 838 1.5× 283 0.8× 200 1.0× 82 0.5× 52 0.4× 34 1.1k
Carmen Terán Spain 21 738 1.3× 213 0.6× 471 2.3× 364 2.3× 47 0.3× 74 1.3k
Jacques Joubert South Africa 20 611 1.1× 292 0.8× 368 1.8× 184 1.2× 39 0.3× 63 1.1k
Frédéric Ooms Belgium 10 339 0.6× 252 0.7× 210 1.0× 194 1.2× 42 0.3× 25 705
Yong Deng China 26 831 1.5× 976 2.6× 369 1.8× 609 3.9× 47 0.3× 74 1.8k
Donatella Bagetta Italy 13 228 0.4× 258 0.7× 190 0.9× 158 1.0× 28 0.2× 17 554

Countries citing papers authored by Jerad Suresh

Since Specialization
Citations

This map shows the geographic impact of Jerad Suresh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerad Suresh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerad Suresh more than expected).

Fields of papers citing papers by Jerad Suresh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerad Suresh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerad Suresh. The network helps show where Jerad Suresh may publish in the future.

Co-authorship network of co-authors of Jerad Suresh

This figure shows the co-authorship network connecting the top 25 collaborators of Jerad Suresh. A scholar is included among the top collaborators of Jerad Suresh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerad Suresh. Jerad Suresh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mathew, Bijo, et al.. (2017). Monoamine oxidase inhibitory activity of methoxy-substituted chalcones. International Journal of Biological Macromolecules. 104(Pt A). 1321–1329. 55 indexed citations
3.
Suresh, Jerad, et al.. (2017). Discovery of potent and reversible MAO-B inhibitors as furanochalcones. International Journal of Biological Macromolecules. 108. 660–664. 41 indexed citations
4.
Mathew, Bijo, et al.. (2016). Pharmacophore Modeling, 3D-QSAR and Molecular Docking of Furanochalcones as Inhibitors of Monoamine Oxidase-B. Central Nervous System Agents in Medicinal Chemistry. 16(2). 105–111. 6 indexed citations
5.
Mathew, Bijo, Githa Elizabeth Mathew, Jerad Suresh, et al.. (2016). Monoamine Oxidase Inhibitors: Perspective Design for the Treatment of Depression and Neurological Disorders. Current Enzyme Inhibition. 12(2). 115–122. 31 indexed citations
6.
Mathew, Bijo, et al.. (2016). Synthesis, ADME studies, toxicity estimation, and exploration of molecular recognition of thiophene based chalcones towards monoamine oxidase-A and B. Beni-Suef University Journal of Basic and Applied Sciences. 5(4). 396–401. 10 indexed citations
7.
Mathew, Bijo, et al.. (2015). Monoamine Oxidase Inhibitory Action of Chalcones: A Mini Review. Central Nervous System Agents in Medicinal Chemistry. 16(2). 120–136. 64 indexed citations
8.
Mathew, Bijo, et al.. (2015). Hydrazones as a Privileged Structural Linker in Antitubercular Agents: A Review. Infectious Disorders - Drug Targets. 15(2). 76–88. 38 indexed citations
9.
Mathew, Bijo, Gülberk Uçar, İpek Baysal, et al.. (2015). Development of Fluorinated Thienylchalcones as Monoamine Oxidase-B Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Letters in Organic Chemistry. 12(9). 605–613. 43 indexed citations
11.
Mathew, Bijo, et al.. (2015). Flavonoids: An Outstanding Structural Core for the Inhibition of Xanthine Oxidase Enzyme. Current Enzyme Inhibition. 11(2). 108–115. 25 indexed citations
12.
Mathew, Bijo, et al.. (2015). Psychomotor Seizure Screening and in vitro Neuroprotection Assay of Hydrazones Derived from 2-Acetyl Thiophene. Central Nervous System Agents in Medicinal Chemistry. 17(1). 51–57. 2 indexed citations
13.
Mathew, Bijo, Jerad Suresh, S. Anbazhagan, & Githa Elizabeth Mathew. (2014). Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase. Central Nervous System Agents in Medicinal Chemistry. 13(3). 195–206. 45 indexed citations
14.
Mathew, Bijo, Jerad Suresh, S. Anbazhagan, & Vinod Devaraji. (2014). Hypnotic Profile of Imines from Benzimidazole Chalcones: Mechanism of Synthesis, DFT Studies and in silico Screening. Central Nervous System Agents in Medicinal Chemistry. 13(3). 207–216. 3 indexed citations
15.
Mathew, Bijo, et al.. (2014). Design, Synthesis, Toxicity Estimation and Molecular Docking Studies of N-(furan-2-yl)-1-(5-substituted) phenyl-1,3,4-oxadiazol-2-yl) methanimine as Antitubercular Agents.. PubMed. 76(5). 401–6. 9 indexed citations
16.
17.
Mathew, Bijo, Jerad Suresh, & S. Anbazhagan. (2014). Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides. PubMed. 13. 437–45. 17 indexed citations
18.
Mathew, Bijo, et al.. (2014). Plant Secondary Metabolites- Potent Inhibitors of Monoamine Oxidase Isoforms. Central Nervous System Agents in Medicinal Chemistry. 14(1). 28–33. 29 indexed citations
19.
Mathew, Bijo, Jerad Suresh, S. Anbazhagan, & N. Chidambaranathan. (2013). Discovery of some novel imines of 2-amino, 5-thio, 1,3,4-thiadiazole as mucomembranous protector. Synthesis, anti-oxidant activity and in silico PASS approach. Journal of Saudi Chemical Society. 20. S426–S432. 10 indexed citations
20.
Mathew, Bijo, et al.. (2013). Synthesis and PASS-assisted in silico approach of some novel 2-substituted benzimidazole bearing a pyrimidine-2, 4, 6(trione) system as mucomembranous protector. Journal of Pharmacy And Bioallied Sciences. 5(1). 39–39. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026